Advertisement

Index by author

March 01, 1994; Volume 22,Issue 2

  1. Agostini, O

    1. Metabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.
      O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G Moneti
      Drug Metabolism and Disposition March 1994, 22 (2) 259-268;

  2. Arison, B H

    1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
      S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M Hoffman
      Drug Metabolism and Disposition March 1994, 22 (2) 200-205;

  3. Balani, S K

    1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
      S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M Hoffman
      Drug Metabolism and Disposition March 1994, 22 (2) 200-205;
    2. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
      T Prueksaritanont, L M Dwyer, S K Balani and A D Theoharides
      Drug Metabolism and Disposition March 1994, 22 (2) 281-288;

  4. Baldeck, J P

    1. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
      V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R Tynes
      Drug Metabolism and Disposition March 1994, 22 (2) 269-274;

  5. Bekersky, I

    1. The pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition March 1994, 22 (2) 233-236;

  6. Bonacchi, G

    1. Metabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.
      O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G Moneti
      Drug Metabolism and Disposition March 1994, 22 (2) 259-268;

  7. Bork, V

    1. Milacemide metabolism in rat liver and brain slices by solids NMR.
      J R Garbow, W P Ridley, V Bork, Y Pan and J Schaefer
      Drug Metabolism and Disposition March 1994, 22 (2) 298-303;

  8. Brouwer, K L

    1. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.
      A B Suttle and K L Brouwer
      Drug Metabolism and Disposition March 1994, 22 (2) 224-232;

  9. Bruelisauer, A

    1. Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
      A Bruelisauer, R Kawai, P Misslin and M Lemaire
      Drug Metabolism and Disposition March 1994, 22 (2) 194-199;

  10. Chen, Q

    1. Salicylate inhibits the renal transport of inorganic sulfate in rat membrane vesicle preparations.
      I M Darling, M L Mammarella, Q Chen and M E Morris
      Drug Metabolism and Disposition March 1994, 22 (2) 318-323;
« Previous (Pages : 1 2 3 4 5 6 ... 12) Next »
Back to top

In this issue

Advertisement